Evidence map›Paper›PMID 21435589›Full record

ArticleImmunity2011

CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model.

Pushpa Pandiyan, Heather R Conti, Lixin Zheng, Alanna C Peterson, Douglas R Mathern, Nydiaris Hernández-Santos, Mira Edgerton, Sarah L Gaffen, Michael J Lenardo

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 280 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Enrichment ofFrontiers in immunology · 2026
    Article
  5. Article
  6. Review
  7. Role of regulatory immune cells in pathogenesis and therapy of periodontitis.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Extracutaneous sporotrichosis.Clinical microbiology reviews · 2025
    Review
  12. Potential Pathogens Associated with Colorectal Cancer.Current pharmaceutical biotechnology · 2025
    Review
  13. Article
  14. Article
  15. Candidiasis in breast cancer: Tumor progression or not?Iranian journal of basic medical sciences · 2024
    Review
  16. Article
  17. Article
  18. Th17/Treg Imbalance: Implications in Lung Inflammatory Diseases.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Review

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Pushpa PandiyanLaboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Heather R Conti
Lixin Zheng
Alanna C Peterson
Douglas R Mathern
Nydiaris Hernández-Santos
Mira Edgerton
Sarah L Gaffen
Michael J Lenardo
University at Buffalo, State University of New York · USUniversity of Pittsburgh · USNational Institute of Allergy and Infectious Diseases · US

Funding

GENE REGULATORY EVENTS IN ESTABLISHING MATURE T CELL TOLERANCEZIAAI000566 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, HELEN CHUN-HUI · 2009 to 2025
$11.4M
TRAINING PROGRAM IN PERIODONTAL DISEASEST32DE007034 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SCANNAPIECO, FRANK ANDREW · 1985 to 2008
$3.5M
Structure-Function Relationships in the IL-17 ReceptorR01AR054389 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2008 to 2012
$1.8M
Immunity to Oral CandidiasisR21DE018822 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2008 to 2009
$417k
TITANIUM ALLOYS FOR PARTIAL DENTURESR43DE007034 · NIDCR · GREENMARK, INC. · PI MARKER, BERNARD C · 1985 to 1985
–
Intramural NIH HHSNIAMS NIH HHS AR054389NIAMS NIH HHS R01 AR054389NIDCR NIH HHS DE007034NIDCR NIH HHS DE0188122NIDCR NIH HHS R21 DE018822NIDCR NIH HHS T32 DE007034
6 · The paper itself

Abstract

Th17 cells and CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells are thought to promote and suppress inflammatory responses, respectively. Here we explore why under Th17 cell polarizing conditions, Treg cells did not suppress, but rather upregulated, the expression of interleukin-17A (IL-17A), IL-17F, and IL-22 from responding CD4(+) T cells (Tresp cells). Upregulation of IL-17 cytokines in Tresp cells was dependent on consumption of IL-2 by Treg cells, especially at early time points both in vitro and in vivo. During an oral Candida albicans infection in mice, Treg cells induced IL-17 cytokines in Tresp cells, which markedly enhanced fungal clearance and recovery from infection. These findings show how Treg cells can promote acute Th17 cell responses to suppress mucosal fungus infections and reveal that Treg cells have a powerful capability to fight infections besides their role in maintaining tolerance or immune homeostasis.

Indexed as

Immunity, InnateAnimalsCandida albicansCandidiasisCD4 AntigensCell DifferentiationDisease Models, AnimalForkhead Transcription FactorsInterleukin-2 Receptor alpha SubunitMiceMice, Inbred BALB CMice, Inbred C57BLTh17 CellsT-Lymphocytes, RegulatoryCD4 AntigensForkhead Transcription FactorsFOXP3 protein, humanInterleukin-2 Receptor alpha Subunit

Identifiers

PMID21435589
PMCPMC3258585
OpenAlexW1991036879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.